flow trial semaglutide kidney outcomes nejm 2024 hazard ratio Long-term of in obesity and cardiovascular disease in the SELECT Effects of semaglutide flow trial semaglutide kidney outcomes

Higher doses increase side effect intensity and cost without proportionally increasing weight loss for patients already responding well

The whole process was easy and straightforward

Cruelty-free | Vegan | Paraben-free

A randomized, double-blind, placebo-controlled trial with that same dose equivalent to half a cup (80 g) of cooked greens, and there was a significant decrease in body weight, fat mass, waist circumference, waist-to-height ratio, and body mass index (BMI) compared to placeboand, by a decent amount

Clinical trials have followed patients for multiple years without identifying new safety concerns that emerge with longer use